enVVeno Medical Corporation (NVNO)
NASDAQ: NVNO · Real-Time Price · USD
8.98
+0.19 (2.10%)
At close: Sep 18, 2026, 4:00 PM EDT
9.15
+0.18 (1.95%)
After-hours: Sep 18, 2026, 4:20 PM EDT
enVVeno Medical Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
33
Market Cap
6.13M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Trinity Biotech | 43.79M |
| WORK Medical Technology Group LTD | 10.72M |
| INVO Fertility | 7.53M |
| Intelligent Bio Solutions | 4.22M |
| IceCure Medical | 3.95M |
| VolitionRx | 2.46M |
| Co-Diagnostics | 721.39K |
| Phaos Technology Holdings (Cayman) Limited | 103.68K |
NVNO News
- 3 days ago - enVVeno Medical trading resumes - TheFly
- 3 days ago - enVVeno Medical trading halted, volatility trading pause - TheFly
- 8 days ago - enVVeno Medical Presentation from H.C. Wainwright Conference Now Available On-Demand - Accesswire
- 23 days ago - enVVeno Medical Participates in the Virtual Investor 'Why Now' On-Demand Conference - Accesswire
- 4 weeks ago - enVVeno Medical files $100M mixed securities shelf - TheFly
- 6 weeks ago - enVVeno announces publication of independent health economic study - TheFly
- 6 weeks ago - Independent Health Economic Study Recently Published in Journal of Vascular Surgery Reports Economic Dominance of enVVeno Medical's Replacement Venous Valve Therapy Compared to Standard of Care Treatments - Accesswire
- 7 weeks ago - enVVeno Medical reports Q2 EPS ($5.37) vs. ($11.52) last year - TheFly